FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION

项目摘要 药物发现、开发和转化论坛为以下方面提供了一个独特的平台： 政府、学术界、教育界和社会各界的思想领袖和利益攸关方之间的对话与合作， 行业，基金会和患者倡导，对改善药物系统感兴趣 发现、发展和翻译。论坛汇集了私营部门的领导人 生物医学和临床研究的赞助商，赞助和管理的联邦机构 生物医学和临床研究，学术界和患者，并在这样做的服务 教育政策界关于科学和政策交叉的问题。目的是 促进跨部门和机构的对话和讨论，并阐明问题，但 必须解决它们。论坛成员确定其希望讨论的主题， 在工作人员的协助下，组织公开会议、内部讨论、专题讨论会， 合作。论坛不就任何具体问题提供意见或建议， 政策在任何政府机构面前悬而未决;总结报告将由公众产生 两会 该论坛每年召开几次会议，以确定、讨论和解决关键问题， 在药物的发现，开发和翻译的战略。补充 论坛还举办公开研讨会，重点讨论 公众对药物开发关键领域的高度关注。会议摘要 通过印刷报告和论坛网站向公众传播。除了大型 公共研讨会，论坛活动吸引了广泛的专家，政策界， 在非正式的场合。论坛成员和外部 专家组成若干工作组，深入审查高度优先问题。此外该 论坛委托或编写论文，以开展新的研究并综合现有的 文献，并探讨有关选定专题的科学和政策问题。论坛还鼓励 其成员和选区之间的合作。

Project Summary The Forum on Drug Discovery, Development, and Translation provides a unique platform for dialogue and collaboration among thought leaders and stakeholders in government, academia, industry, foundations, and patient advocacy with an interest in improving the system of drug discovery, development, and translation. The Forum brings together leaders from private sector sponsors of biomedical and clinical research, federal agencies sponsoring and regulating biomedical and clinical research, the academic community, and patients, and in doing so serves to educate the policy community about issues where science and policy intersect. The purpose is to foster dialogue and discussion across sectors and institutions, and to illuminate issues, but not necessarily resolve them. The Forum membership identifies topics that it wishes to address, and with assistance from staff, develops public meetings, internal discussions, symposia, and collaborations. The Forum does not provide advice or recommendations on any specific issue or policy pending before any government agency; summary reports will result from the public conferences. The Forum convenes several times each year to identify, discuss, and act on key problems and strategies in the discovery, development, and translation of drugs. To supplement the perspectives and expertise of its members, the Forum also holds public workshops to focus substantial public attention on critical areas of drug development. Summaries of these meetings are disseminated to the public through printed reports and the Forum website. In addition to large public workshops, Forum activities engage a wide range of experts, the policy community, and members of the public in an informal setting. A combination of Forum members and outside experts comprise several workgroups that examine high-priority issues in depth. In addition, the Forum commissions or develops papers to undertake new research as well as synthesize existing literature and explore scientific and policy issues on selected topics. The Forum also fosters collaborations among its members and constituencies.